Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for controlling citrus gonggan canker

A technology of canker and composition, which is applied in the field of pharmaceutical composition for preventing and treating citrus canker, can solve the problems of low yield and sugar content rate of tribute citrus, general taste and appearance color, short drug effect time, etc., and achieve effective Conducive to popularization and application, the appearance is round and lustrous, and the effect of long-term drug effect

Inactive Publication Date: 2017-04-26
钟山县昱成水果种植专业合作社
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] The invention provides a pharmaceutical composition for preventing and treating citrus canker so as to solve the problem of the current biopesticides with short duration of action and poor effect, as well as the existing drugs for preventing and treating citrus canker that increase the yield and sugar content of citrus cankers after use. Problems such as low weight rate, general taste and appearance color

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for controlling citrus gonggan canker
  • Pharmaceutical composition for controlling citrus gonggan canker

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0055] The preparation method of described prevention and treatment tribute orange canker medicine composition, comprises the following steps:

[0056] S1: Mix and pulverize purslane, tea leaves, pyrethrum, lettuce, weeping willow leaves, kava pepper, tea leaves, and leafless horsetail to obtain mixture I. Add mixture I to ethanol, and the ratio of solid to liquid is 1 : 14-16, the ultrasonic power is 200-300W, the ethanol concentration is 65%-80%, and the extraction temperature is 64-76°C to extract the medicinal solution for 17-23min to obtain the medicinal solution;

[0057] S2: passing the liquid medicine prepared in step S1 through a 3000-5000 mesh sieve to obtain a filtrate;

[0058] S3: adding potassium salt, phosphorus salt, nitrogen salt, calcium salt, magnesium salt, iodine salt, boron salt, molybdenum salt, zinc salt, manganese salt, copper salt, iron salt, vitamin, amino acid, Indolebutyric acid, gibberellin, 6-benzyl adenine, naphthaleneacetic acid, agar, kinetin...

Embodiment 1

[0064] A pharmaceutical composition for preventing and treating citrus canker, in parts by weight, comprising the following raw materials: 126 parts of purslane, 100 parts of tea tree leaves, 90 parts of pyrethrum, 90 parts of lettuce, 75 parts of weeping willow leaves, 65 parts of kava 55 parts of tea tree leaves, 50 parts of leafless horsetail, 2.5 parts of potassium salt, 2 parts of phosphorus salt, 1.5 parts of nitrogen salt, 0.8 part of calcium salt, 0.8 part of magnesium salt, 0.3 part of iodine salt, 0.3 part of boron salt, 0.3 part of molybdenum salt, 0.3 part of zinc salt, 0.3 part of manganese salt, 0.3 part of copper salt, 0.3 part of iron salt, 0.3 part of vitamin, 0.2 part of amino acid, 0.08 part of indole butyric acid, 0.08 part of gibberellin, 6-benzyl 0.07 parts of adenine, 0.05 parts of naphthalene acetic acid, 0.2 parts of agar, 0.05 parts of kinetin, 1.5 parts of N-methylpyrrolidone, 1 part of sodium dinonyl naphthalene sulfonate, 1.4 parts of DuPont EEA2112...

Embodiment 2

[0089] A pharmaceutical composition for preventing and treating citrus canker, comprising the following raw materials in parts by weight: 112 parts of purslane, 92 parts of tea tree leaves, 82 parts of pyrethrum, 82 parts of lettuce, 60 parts of weeping willow leaves, 55 parts of kava 45 parts of tea tree leaves, 40 parts of leafless horsetail, 2 parts of potassium salt, 1 part of phosphorus salt, 1 part of nitrogen salt, 0.6 part of calcium salt, 0.6 part of magnesium salt, 0.2 part of iodine salt, 0.2 part of boron salt, 0.2 part of molybdenum salt, 0.2 part of zinc salt, 0.2 part of manganese salt, 0.2 part of copper salt, 0.2 part of iron salt, 0.2 part of vitamin, 0.2 part of amino acid, 0.06 part of indole butyric acid, 0.06 part of gibberellin, 6-benzyl 0.06 part of adenine, 0.04 part of naphthalene acetic acid, 0.1 part of agar, 0.04 part of kinetin, 0.7 part of N-methylpyrrolidone, 0.6 part of sodium dinonyl naphthalene sulfonate, 1 part of American DuPont EEA2112AC co...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for controlling citrus gonggan canker. The pharmaceutical composition comprises the following raw materials: purslane, tea tree leaf, pyrethrum, lettuce, weeping willow leaf, piper methysticum forst, tea tree leaf, anabasis aphylla, potassium salt, phosphorus salt, nitrogen salt, calcium salt, iodine salt, boron salt, molybdenum salt, zinc salt, manganese salt, copper salt, iron salt, vitamin, amino acid, indolebutyric acid, gibberellins, 6-benzyladenine, naphthylacetic acid, agar, kinetin, N-methyl pyrrolidone, dinonyl sodium naphthalene sulfonate, DUPONT EEA2112AC compatilizer, earthworm powder, alkyl sulfate potassium, trimethylolpropane triacrylate, 3-aminopropyltriethoxysilane, carrageenin, mancozeb, streptomycin, prochloraz, wetting penetrating agent, synergist, and ethanol. The pharmaceutical composition disclosed by the invention is used for controlling the citrus gongan canker, and can improve the yield and the sugar content; and citrus gonggan is good in mouthfeel and high in quality, which are higher than the use effect of a conventional pharmaceutical composition for controlling the citrus gonggan canker.

Description

[0001] 【Technical field】 [0002] The invention belongs to the technical field of disease prevention of tribute oranges, and in particular relates to a pharmaceutical composition for preventing and treating canker of tribute oranges. [0003] 【Background technique】 [0004] Gonggan is one of the excellent citrus varieties with local characteristics in Zhongshan County, Hezhou City. It is quite competitive in the market because of its pure and sweet taste, good taste and special aroma. [0005] Tribute citrus fruit is beautiful in shape, golden in color, thin in skin and few in core, crispy in flesh and slag, clear in sweetness and honey, high in sugar and low in acid, and rich in flavor. , is incomparable to other citrus varieties, and is known as the king of citrus. The average fruit weight of Gongkan is 90-145 grams, the fruit diameter is 60-65 mm, the soluble solids (mainly sugar) are 9.0-12.5%, the edible rate is about 78%, and the sugar content per 100 ml of fruit juice i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A01N65/12A01N43/90A01N37/10A01N63/02A01N37/44A01N43/38A01N43/12A01N47/14A01N47/38A01N47/44A01N59/08A01N59/02A01N59/16A01N59/00A01N59/12A01N59/20A01N59/14A01P1/00A01P21/00
CPCA01N37/10A01N37/44A01N43/12A01N43/38A01N43/90A01N47/14A01N47/38A01N47/44A01N59/00A01N59/02A01N59/08A01N59/12A01N59/14A01N59/16A01N59/20A01N63/10A01N65/00A01N65/12A01N2300/00
Inventor 陈文松
Owner 钟山县昱成水果种植专业合作社
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com